Comparative of PD-L1 expression on live single circulating tumor cells with PD-L1 in tumor tissue assessed by immunohistochemistry in advanced NSCLC patients. This is an ASCO Meeting Abstract from the ...
Scientists have found a way to detect earlier if a deadly cancer, Merkel cell carcinoma (MCC), is recurring in patients, according to a paper to be published 11 a.m. Eastern time, Dec. 7, in the ...
In a prospective study of patients with stages I-III Merkel cell carcinoma (MCC), seropositivity for rising polyomavirus oncoprotein antibody titers conferred a 58% risk for recurrence at 12 months, ...
SEATTLE — May 21, 2026 — Fred Hutch Cancer Center experts will present the latest findings in advancing treatments for blood, skin and breast cancers, as well as new research in palliative care, ...
Genomic analyses of cell-free DNA (cfDNA) in plasma are enabling noninvasive blood-based biomarker approaches to cancer detection and disease monitoring. Current approaches for identification of ...
The alternative text for this image may have been generated using AI. We streamlined the workflow of the EC-SNV-Seq assay for multi-cancer early detection using a pooled plasma sample (Fig. 1b). Equal ...
Researchers found that pembrolizumab, an immune-activating cancer drug, lowered the risk of distant metastases in patients with Merkel cell carcinoma after surgery. Though recurrence rates overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results